The human ELISA Arginase-1 kit quantifyes the Hu renin in human serum, plasma or cell culture medium. The test will recognize only natural and recombinant 1-Hu arginase.
The human ELISA Arginase-1 kit quantifyes the Hu renin in human serum, plasma or cell culture medium. The test will recognize only natural and recombinant 1-Hu arginase.
Method principle
L-ELISA solid phase sandwich of human Argunase-1 (dose d-immunoabsorption by bound enzyme) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), binding to the target on a different epitope from the capture antibody. A conjugate enzyme was incorporated into the assay. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.
Strict validation
Each batch manufactured from this ELISA kit is tested according to its quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
L-arginase-1 is a 35 kDa enzyme that helps remove nitrogen by converting L-arginine to urea and L-ornithine, which then turns into polyamine. These polyamines are important for cell proliferation and elimination of toxins resulting from protein degradation. Its expression is found in the liver, neutrophils, and in myeloid-derived suppressive cells (MDSCs) and neural stem cells. The expression in macrophages was not determined in humans, whereas in mice the expression in M2 macrophages is well established. L-arginase1 can be expressed in the myeloid population of breast cancer tumours and is generally found in the majority of hepatocellular carcinomas.
Sensitivity
Sensitivity of the dosage: 20.81 pg/ml.
Measurement range
Dose range: 78.1–5000 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of variation intra-dose 6.6%, inter-dose 8.5%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 16312004 |
| Specifications |
| Accession number | P05089 |
| Dose range | 78.1–5000 pg/ml |
| Sensitivity of the dosage | 20.81 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Cellular lysates, Serum, Serum |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 383 |
| Gene symbol(s) | ARG1 |
| Coefficient of inter-dose variation | 8.5% |
| Coefficient of intra-dose variation | 6.6% |
| Contents of kits | 96-well pre-coated plate, Standard (2 vials), Sample thinner, Dose buffer concentrate, Biotinylated detection antibody, Streptavidine-HRP, Washing stamp, Substrate solution, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 μl; plasma, 50 μl; cell lysate, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2216 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.